UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

Journal of thoracic oncology, 2020-05, Vol.15 (5), p.860-866

2020

Volltextzugriff (PDF)

Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma

Scientific reports, 2021-11, Vol.11 (1), p.22057-22057, Article 22057

2021

Volltextzugriff (PDF)

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

PloS one, 2016-04, Vol.11 (4), p.e0151662-e0151662

2016

Volltextzugriff (PDF)

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era

Cancers, 2021-08, Vol.13 (15), p.3887

2021

Volltextzugriff (PDF)

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

Cancers, 2021-03, Vol.13 (5), p.1040

2021

Volltextzugriff (PDF)

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

ERJ open research, 2018-04, Vol.4 (2), p.120-2017

2018

Volltextzugriff (PDF)

MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS Panels

Journal of thoracic oncology, 2017-10, Vol.12 (10), p.1582-1587

2017

Volltextzugriff (PDF)

Prognostic impact of TP53 mutations in metastatic non-squamous non-small-cell lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21033-e21033

2023

Volltextzugriff (PDF)

Dépistage ciblé du mélanome en médecine générale : évaluation du taux de participation à l’auto-questionnaire SAMScore

Annales de Dermatologie et de Vénéréologie - FMC, 2021-12, Vol.1 (8), p.A166

2021

Volltextzugriff (PDF)

WITHDRAWN: Women, thrombosis, and cancer

Thrombosis research, 2019-02

2019

Volltextzugriff (PDF)

GALLANT-1: Galectin-3 (Gal-3) inhibitor GB1211 plus atezolizumab (atezo) in patients with non–small cell lung cancer (NSCLC)—A randomized, double-blind trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS9152-TPS9152

2022

Volltextzugriff (PDF)

Women, thrombosis, and cancer

Thrombosis research, 2019-09, Vol.181, p.S47-S53

2019

Volltextzugriff (PDF)

A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors

Clinical cancer research, 2020-02, Vol.26 (3), p.588-597

2020

Volltextzugriff (PDF)

Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas

European journal of cancer (1990), 2018-02, Vol.90, p.83-91

2018

Volltextzugriff (PDF)

One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: A retrospective study

Journal of critical care, 2020-06, Vol.57, p.36-41

2020

Volltextzugriff (PDF)

Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer

Clinical lung cancer, 2024-05, Vol.25 (3), p.244-253.e2

2024

Volltextzugriff (PDF)

A multinational pivotal study of sunvozertinib in platinum pretreated non-small cell lung cancer with EGFR exon 20 insertion mutations: Primary analysis of WU-KONG1 study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8513-8513

2024

Volltextzugriff (PDF)

Prognostic value of hPG 80 (circulating progastrin) in IDH-wild type glioblastoma treated with radio-chemotherapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2049-2049

2022

Volltextzugriff (PDF)

Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series

European journal of cancer (1990), 2019-08, Vol.117, p.116-118

2019

Volltextzugriff (PDF)

Long-term outcomes of patients with HER2+ breast cancer with small-size residual disease (≤ypT1) in the absence of pathological response after trastuzumab-based neoadjuvant chemotherapy and without adjuvant T-DM1: A monocentric retrospective study

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.589-589

2020

Volltextzugriff (PDF)

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era

Cancers, 2021-08, Vol.13 (15)

2021

Volltextzugriff (PDF)

Abstract P5-03-06: Comparison of clinicopathological features and outcome of breast cancer in BRCA-mutation carriers, in patients with a family history without BRCA-mutation and in patients with sporadic disease

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-03-06

2020

Volltextzugriff (PDF)

Prophylaxis of venous thromboembolism in cancer patients

Expert review of hematology, 2016-06, Vol.9 (6), p.535-539

2016

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS Panels

Prognostic impact of TP53 mutations in metastatic non-squamous non-small-cell lung cancer

Dépistage ciblé du mélanome en médecine générale : évaluation du taux de participation à l’auto-questionnaire SAMScore

WITHDRAWN: Women, thrombosis, and cancer

GALLANT-1: Galectin-3 (Gal-3) inhibitor GB1211 plus atezolizumab (atezo) in patients with non–small cell lung cancer (NSCLC)—A randomized, double-blind trial

Women, thrombosis, and cancer

A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors

Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study

One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: A retrospective study

Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer

A multinational pivotal study of sunvozertinib in platinum pretreated non-small cell lung cancer with EGFR exon 20 insertion mutations: Primary analysis of WU-KONG1 study

Prognostic value of hPG 80 (circulating progastrin) in IDH-wild type glioblastoma treated with radio-chemotherapy

Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study

Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series

Long-term outcomes of patients with HER2+ breast cancer with small-size residual disease (≤ypT1) in the absence of pathological response after trastuzumab-based neoadjuvant chemotherapy and without adjuvant T-DM1: A monocentric retrospective study

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era

Abstract P5-03-06: Comparison of clinicopathological features and outcome of breast cancer in BRCA-mutation carriers, in patients with a family history without BRCA-mutation and in patients with sporadic disease

Prophylaxis of venous thromboembolism in cancer patients

Suchergebnisse filtern